ArticlePloS one2019

Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.

Camille Tumiotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.